TY - JOUR
KW - Addiction
KW - Alcohol Deterrents/administration & dosage/adverse effects/therapeutic use
KW - Alcohol use disorder
KW - Alcoholism/drug therapy
KW - Anticonvulsants/administration & dosage/adverse effects/therapeutic use
KW - Comorbidity
KW - Drug Therapy, Combination
KW - FDA approved
KW - Humans
KW - Medication Adherence
KW - Narcotic Antagonists/administration & dosage/adverse effects/therapeutic use
KW - Nicotinic Agonists/administration & dosage/adverse effects/therapeutic use
KW - Off-label
KW - Off-Label Use
KW - Patient Care Planning
KW - Personalized medicine
KW - pharmacotherapy
KW - United States
KW - Withdrawal
AU - S. R. Holt
AU - D. G. Tobin
A1 - 
BT - The Medical clinics of North America
C5 - Opioids & Substance Use; Education & Workforce
CP - 4
CY - United States
IS - 4
JF - The Medical clinics of North America
PB - Elsevier Inc
PP - United States
PY - 2018
SN - 1557-9859; 0025-7125
SP - 653
EP - 666
EP - 
T1 - Pharmacotherapy for Alcohol Use Disorder
T2 - The Medical clinics of North America
TI - Pharmacotherapy for Alcohol Use Disorder
U1 - Opioids & Substance Use; Education & Workforce
U2 - 29933821
VL - 102
VO - 1557-9859; 0025-7125
Y1 - 2018
ER -